Status:
COMPLETED
Bindex for Osteoporosis Diagnostics
Lead Sponsor:
Bone Index Finland Ltd
Collaborating Sponsors:
New Mexico Clincial Research & Osteoporosis Center, Inc.
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
50-100 years
Brief Summary
Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, th...
Detailed Description
Currently, the diagnosis of osteoporosis is based on the measurement of bone mineral density (BMD), using axial dual energy X-ray absorptiometry (DXA) of the hip and/or the lumbar spine at special hea...
Eligibility Criteria
Inclusion
- Inclusion Criteria for all:
- Postmenopausal status
- Age at 50 years or over
- Caucasian or Hispanic race (number shall be controlled, 140 in each group)
- Body mass index (BMI \< 35)
- Additional criteria for Osteoporotic group
- \- T-Score (NHANES database) -2.5 or lower at femoral neck or total femur
- Additional criteria for non-osteoporotic group
- \- T-Score (NHANES database) \> -2.5 at femoral neck or total femur
- Exclusion Criteria:
- for non-osteoporotic groups (Hispanic or Caucasian)
- Previous osteoporosis diagnosis
- Previous or current use of anti-fracture medication
Exclusion
Key Trial Info
Start Date :
March 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2020
Estimated Enrollment :
293 Patients enrolled
Trial Details
Trial ID
NCT03878732
Start Date
March 11 2019
End Date
February 7 2020
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Mexico Clincial Research & Osteoporosis Center, Inc.
Albuquerque, New Mexico, United States, 87106